See more : Federal Home Loan Mortgage Corporation (FMCCS) Income Statement Analysis – Financial Results
Complete financial analysis of Creative Edge Nutrition, Inc. (FITX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Creative Edge Nutrition, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Imagination Technologies (IGZ) Income Statement Analysis – Financial Results
- Mogul Games Group Ltd (MGG.AX) Income Statement Analysis – Financial Results
- Beijing SuperMap Software Co., Ltd. (300036.SZ) Income Statement Analysis – Financial Results
- Pembina Pipeline Corporation (PMBPF) Income Statement Analysis – Financial Results
- NTT Data Intramart Corporation (3850.T) Income Statement Analysis – Financial Results
Creative Edge Nutrition, Inc. (FITX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cenergynutrition.com
About Creative Edge Nutrition, Inc.
Creative Edge Nutrition, Inc. develops and sells a portfolio of healthoriented nutrition products. The company offers products in the categories of weight loss, metabolic enhancement, recovery/well-being, muscle enhancement and stimulation, and natural line. Its products include MetaBolic Xtreme, a product for weight loss; Hyper-Infusion, a pre-workout powder to enhance endurance and strength; Alpha-Drive, a product for post cycle therapy; Amino Plex, an intra-workout recovery catalyst; Chia Plex, a product for health and well being; and Hemp Nutra Tea and Nutra Coffee additives. The company was formerly known as Laufer Bridge Enterprises Inc. and changed its name to Creative Edge Nutrition, Inc. in April 2012. Creative Edge Nutrition, Inc. is based in Madison Heights, Michigan.
| Metric | 2009 | 2008 | 2007 |
|---|---|---|---|
| Revenue | 115.21K | 409.07K | 366.10K |
| Cost of Revenue | 22.69K | 0.00 | 0.00 |
| Gross Profit | 92.53K | 409.07K | 366.10K |
| Gross Profit Ratio | 80.31% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 200.25K | 408.09K | 314.93K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 200.25K | 408.09K | 314.93K |
| Other Expenses | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 200.25K | 408.09K | 314.93K |
| Cost & Expenses | 222.94K | 408.09K | 314.93K |
| Interest Income | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 890.00 | 384.00 | 3.34K |
| EBITDA | -106.84K | 1.36K | 54.51K |
| EBITDA Ratio | -103.58% | 0.33% | 14.89% |
| Operating Income | -107.73K | 978.00 | 51.17K |
| Operating Income Ratio | -93.50% | 0.24% | 13.98% |
| Total Other Income/Expenses | 12.50K | 0.00 | 0.00 |
| Income Before Tax | -95.23K | 0.00 | 0.00 |
| Income Before Tax Ratio | -82.65% | 0.00% | 0.00% |
| Income Tax Expense | -12.50K | 0.00 | 0.00 |
| Net Income | -95.23K | 978.00 | 51.17K |
| Net Income Ratio | -82.65% | 0.24% | 13.98% |
| EPS | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 195.99M | 12.04M | 11.40M |
| Weighted Avg Shares Out (Dil) | 195.99M | 12.04M | 11.40M |
Source: https://incomestatements.info
Category: Stock Reports